Forsta AP Fonden boosted its stake in shares of Dr Pepper Snapple Group, Inc (NYSE:DPS) by 14.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 74,021 shares of the company’s stock after purchasing an additional 9,623 shares during the quarter. Forsta AP Fonden’s holdings in Dr Pepper Snapple Group were worth $6,549,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its position in Dr Pepper Snapple Group by 2.9% during the second quarter. Vanguard Group Inc. now owns 18,408,234 shares of the company’s stock worth $1,677,174,000 after purchasing an additional 510,155 shares during the period. BlackRock Inc. boosted its position in Dr Pepper Snapple Group by 4.9% during the second quarter. BlackRock Inc. now owns 17,172,007 shares of the company’s stock worth $1,564,543,000 after purchasing an additional 802,560 shares during the period. JPMorgan Chase & Co. boosted its position in Dr Pepper Snapple Group by 0.9% during the second quarter. JPMorgan Chase & Co. now owns 8,399,141 shares of the company’s stock worth $765,245,000 after purchasing an additional 75,164 shares during the period. FMR LLC boosted its position in Dr Pepper Snapple Group by 4.7% during the second quarter. FMR LLC now owns 2,984,283 shares of the company’s stock worth $271,898,000 after purchasing an additional 134,256 shares during the period. Finally, Wells Fargo & Company MN boosted its position in Dr Pepper Snapple Group by 0.7% during the second quarter. Wells Fargo & Company MN now owns 2,259,175 shares of the company’s stock worth $205,835,000 after purchasing an additional 15,523 shares during the period. 90.73% of the stock is owned by hedge funds and other institutional investors.

In other Dr Pepper Snapple Group news, insider Angela A. Stephens sold 7,700 shares of the business’s stock in a transaction dated Friday, September 1st. The stock was sold at an average price of $91.12, for a total transaction of $701,624.00. Following the completion of the transaction, the insider now owns 6,053 shares of the company’s stock, valued at $551,549.36. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Angela A. Stephens sold 3,160 shares of the business’s stock in a transaction dated Wednesday, August 16th. The stock was sold at an average price of $92.51, for a total value of $292,331.60. Following the transaction, the insider now directly owns 16,913 shares of the company’s stock, valued at approximately $1,564,621.63. The disclosure for this sale can be found here. 0.58% of the stock is owned by insiders.

WARNING: This report was reported by Daily Political and is the property of of Daily Political. If you are accessing this report on another publication, it was illegally copied and republished in violation of international trademark & copyright laws. The original version of this report can be viewed at https://www.dailypolitical.com/2017/11/06/dr-pepper-snapple-group-inc-dps-shares-bought-by-forsta-ap-fonden.html.

A number of equities analysts have commented on DPS shares. BMO Capital Markets reaffirmed a “buy” rating and set a $105.00 price objective on shares of Dr Pepper Snapple Group in a research report on Wednesday, July 12th. Cowen and Company reaffirmed a “hold” rating and set a $96.00 price objective on shares of Dr Pepper Snapple Group in a research report on Friday, July 14th. Susquehanna Bancshares Inc set a $96.00 price objective on shares of Dr Pepper Snapple Group and gave the stock a “hold” rating in a research report on Thursday, July 27th. Credit Suisse Group set a $107.00 price objective on shares of Dr Pepper Snapple Group and gave the stock a “buy” rating in a research report on Thursday, July 27th. Finally, UBS AG lifted their price objective on shares of Dr Pepper Snapple Group from $98.00 to $99.00 and gave the stock a “neutral” rating in a research report on Friday, July 28th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and six have assigned a buy rating to the company’s stock. Dr Pepper Snapple Group currently has a consensus rating of “Hold” and an average price target of $99.45.

Dr Pepper Snapple Group, Inc (DPS) opened at $85.62 on Monday. The company has a market capitalization of $15,457.96, a PE ratio of 19.46, a P/E/G ratio of 2.15 and a beta of 0.57. Dr Pepper Snapple Group, Inc has a 52 week low of $81.05 and a 52 week high of $99.47. The company has a debt-to-equity ratio of 2.07, a current ratio of 0.93 and a quick ratio of 0.74.

Dr Pepper Snapple Group (NYSE:DPS) last posted its quarterly earnings results on Wednesday, October 25th. The company reported $1.10 EPS for the quarter, missing the Zacks’ consensus estimate of $1.16 by ($0.06). The company had revenue of $1.74 billion during the quarter, compared to analyst estimates of $1.77 billion. Dr Pepper Snapple Group had a net margin of 11.06% and a return on equity of 37.53%. The firm’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same period last year, the firm earned $1.17 EPS. equities analysts expect that Dr Pepper Snapple Group, Inc will post 4.54 EPS for the current year.

Dr Pepper Snapple Group Profile

Dr Pepper Snapple Group, Inc is an integrated brand owner, manufacturer and distributor of non-alcoholic beverages in the United States, Mexico and Canada. The Company offers a diverse portfolio of flavored (non-cola) carbonated soft drinks (CSDs) and non-carbonated beverages (NCBs), including ready-to-drink teas, juices, juice drinks, water and mixers.

Want to see what other hedge funds are holding DPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dr Pepper Snapple Group, Inc (NYSE:DPS).

Institutional Ownership by Quarter for Dr Pepper Snapple Group (NYSE:DPS)

Receive News & Ratings for Dr Pepper Snapple Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dr Pepper Snapple Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.